Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk

  • Guenter Hofmann
  • Uwe Langsenlehner
  • Wilfried Renner
  • Tanja Langsenlehner
  • Babak Yazdani-Biuki
  • Heimo Clar
  • Armin Gerger
  • Martin Wehrschuetz
  • Hellmut Samonigg
  • Peter Krippl
Original Paper



Tumor growth requires the formation of new blood vessels, a phenomenon known as angiogenesis. The most important regulator of angiogenesis is vascular endothelial growth factor (VEGF). Several common polymorphisms in the VEGF-gene have been associated with different VEGF expression, production and plasma levels according to allele status, and influence the risk of developing different types of cancer. Therefore, these variants might be risk factors for colorectal cancer (CRC).


In the present case–control study, VEGF genotypes of the +936 C > T, −2578 C > A and −634 G > C polymorphisms were determined in 427 patients with histologically verified CRC and 427 age and sex-matched healthy control subjects. Genotypes were analyzed by a fluorogenic exonuclease assay (TaqMan™). P-value for age at diagnosis was analyzed by student’s t test, P-values for tumor characteristics were determined by Pearson’s Chi-square test. Threshold for significance was P < 0.05.


At the time of diagnoses, patients were between 29 and 83 years of age, with a mean age of 61 ± 10.9 years. VEGF −2578 C > A and VEGF −634 G > C genotype frequencies were similar among patients and controls. Carriers of the 936T-allele were found slightly more frequent among controls (27.2%) than among patients (22.5%), but this difference did not reach statistical significance (P = 0.07). Furthermore, no correlation was found between all these variants and tumor characteristics like size, histological grading, positive regional lymph node metastases or tumor stage.


We conclude that the investigated polymorphisms are not associated with individual susceptibility to colorectal cancer.


Colorectal Cancer Susceptibility VEGF Polymorphisms 



This study was supported by the “Austrian Cancer Aid/Styria” (project no. 02/2005)


  1. Ahmed FE (2003) Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 21(2):65–131PubMedGoogle Scholar
  2. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K et al (2002) A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51(5):1635–1639PubMedCrossRefGoogle Scholar
  3. Balasubramanian SP, Cox A, Cross SS, Higham SE, Brown NJ, Reed MW (2007) Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 121(5):1009–1016PubMedCrossRefGoogle Scholar
  4. Butt C, Lim S, Greenwood CM, Rahman P (2007) VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet Disord 8(1):1PubMedCrossRefGoogle Scholar
  5. Cappell MS (2005) From colonic polyps to colon cancer: pathophysiology, clinical presentation, and diagnosis. Clin Lab Med 25(1):135–177PubMedCrossRefGoogle Scholar
  6. Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3):4–10PubMedCrossRefGoogle Scholar
  7. Eroglu A, Gulec S, Kurtman C, Cam R, Akar N (2006) Vascular endothelial growth factor 936 C/T polymorphism in cancer patients. Ann Oncol 17(9):1467–1468PubMedCrossRefGoogle Scholar
  8. Garcia-Closas M, Malats N, Real FX, Yeager M, Welch R, Silverman D et al (2007) Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 3(2):e29PubMedCrossRefGoogle Scholar
  9. Han SW, Kim GW, Seo JS, Kim SJ, Sa KH, Park JY et al (2004) VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxford) 43(9):1173–1177CrossRefGoogle Scholar
  10. Hefler LA, Mustea A, Konsgen D, Concin N, Tanner B, Strick R et al (2007) Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin Cancer Res 13(3):898–901PubMedCrossRefGoogle Scholar
  11. Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL et al (2006) Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 8(2):R22PubMedCrossRefGoogle Scholar
  12. Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R et al (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11(10):3647–3653PubMedCrossRefGoogle Scholar
  13. Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT et al (2006) Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 15(6):1148–1152PubMedCrossRefGoogle Scholar
  14. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Sivridis E (2004) VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46(3):293–298PubMedCrossRefGoogle Scholar
  15. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC et al (2003) A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106(4):468–471PubMedCrossRefGoogle Scholar
  16. Lee SJ, Lee SY, Jeon HS, Park SH, Jang JS, Lee GY et al (2005) Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 14(3):571–575PubMedCrossRefGoogle Scholar
  17. Lu H, Shu XO, Cui Y, Kataoka N, Wen W, Cai Q et al (2005) Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 65(12):5015–5019PubMedCrossRefGoogle Scholar
  18. Medford AR, Keen LJ, Bidwell JL, Millar AB (2005) Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax 60(3):244–248PubMedCrossRefGoogle Scholar
  19. Nam EJ, Han SW, Kim SU, Cho JH, Sa KH, Lee WK et al (2005) Association of vascular endothelial growth factor gene polymorphisms with Behcet disease in a Korean population. Hum Immunol 66(10):1068–1073PubMedCrossRefGoogle Scholar
  20. Nikiteas NI, Tzanakis N, Theodoropoulos G, Atsaves V, Christoni Z, Karakitsos P et al (2007) Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer 10(1):12–17PubMedCrossRefGoogle Scholar
  21. Onen IH, Konac E, Eroglu M, Guneri C, Biri H, Ekmekci A (2007) No association between polymorphism in the vascular endothelial growth factor gene at position-460 and sporadic prostate cancer in the Turkish population. Mol Biol Rep (in press)Google Scholar
  22. Papapolychroniadis C (2004) Environmental and other risk factors for colorectal carcinogenesis. Tech Coloproctol 8(Suppl 1):s7–s9PubMedCrossRefGoogle Scholar
  23. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108PubMedCrossRefGoogle Scholar
  24. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2000) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37(6):443–448PubMedCrossRefGoogle Scholar
  25. Rougier P, Andre T, Panis Y, Colin P, Stremsdoerfer N, Laurent-Puig P (2006) Colon cancer. Gastroenterol Clin Biol 30(Spec No 2):2S24–2S29PubMedGoogle Scholar
  26. Roy H, Bhardwaj S, Yla-Herttuala S (2006) Biology of vascular endothelial growth factors. FEBS Lett 580(12):2879–2887PubMedCrossRefGoogle Scholar
  27. Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L (2006) Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 35(1–2):21–28PubMedCrossRefGoogle Scholar
  28. Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV et al (2002) Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13(1):260–264PubMedGoogle Scholar
  29. Tzanakis N, Gazouli M, Rallis G, Giannopoulos G, Papaconstantinou I, Theodoropoulos G et al (2006) Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 94(7):624–630PubMedCrossRefGoogle Scholar
  30. Wang WS, Chen PM, Su Y (2006) Colorectal carcinoma: from tumorigenesis to treatment. Cell Mol Life Sci 63(6):663–671PubMedCrossRefGoogle Scholar
  31. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12(8):1232–1235PubMedCrossRefGoogle Scholar
  32. Yamamori M, Sakaeda T, Nakamura T, Okamura N, Tamura T, Aoyama N et al (2004) Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. Biochem Biophys Res Commun 325(1):144–150PubMedCrossRefGoogle Scholar
  33. Yapijakis C, Vairaktaris E, Vassiliou S, Vylliotis A, Nkenke E, Nixon AM et al. (2007) The low VEGF production allele of the +936 C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol 133(10):787–791PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Guenter Hofmann
    • 1
  • Uwe Langsenlehner
    • 1
  • Wilfried Renner
    • 2
  • Tanja Langsenlehner
    • 3
  • Babak Yazdani-Biuki
    • 4
  • Heimo Clar
    • 5
  • Armin Gerger
    • 1
  • Martin Wehrschuetz
    • 6
  • Hellmut Samonigg
    • 1
  • Peter Krippl
    • 7
  1. 1.Division of Oncology, Department of Internal MedicineMedical University of GrazGrazAustria
  2. 2.Clinical Institute of Medical and Chemical Laboratory DiagnosticsMedical University of GrazGrazAustria
  3. 3.Department of Therapeutic Radiology and OncologyMedical University of GrazGrazAustria
  4. 4.Division of Rheumatology, Department of Internal MedicineMedical University of GrazGrazAustria
  5. 5.Department of Orthopedic SurgeryMedical University of GrazGrazAustria
  6. 6.Division of General Radiological Diagnostics, Department of RadiologyMedical University of GrazGrazAustria
  7. 7.Department of Internal MedicineRegional Hospital of FuerstenfeldFuerstenfeldAustria

Personalised recommendations